There was a period, as COVID-19 vaccinations were approved and then shipped, that the tide of rising cases and deaths would turn by the end of winter or early spring. A faster spreading mutation…
The start of the new year brought another grim milestone. U.S. fatal cases topped 350,000. Almost every model of future deaths puts the sum at about 400,000 by the time Joe Biden is sworn…
Currently, the United States has 20,331,785 confirmed COVID-19 cases. That increased by 175,393 yesterday and now routinely rises by over 200,000 in a day. Coronavirus deaths stand at 350,853, up by 2,480. The daily…
CDC data show that, as of New Year’s Eve, approximately 12.4 million doses of the Pfizer and Moderna vaccines had been distributed across America. Of these only 2.8 million had been administered. The totals…
CDC data show that, as of New Year’s Eve, approximately 12.4 million doses of the Pfizer and Moderna vaccines had been distributed across America. Of these only 2.8 million had been administered. The totals…
By official counts, COVID-19 confirmed cases in the U.S. have just crossed 20 million. Deaths set a single-day record two days ago at 3,725. A small portion of those death were figures reported late…
A hospital quality and safety research firm has released its latest hospital safety grades, and 16 hospitals across the country received the lowest possible grade.
The figures for COVID-19 cases and deaths vary widely from state to state, as well as by county in each state.
One question the residents of this county must have asked themselves is whether matters will get worse. If they are like the rest of the country, the future is grim.
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
These are five top picks for 2021 from Jefferies for investors looking to add health care stocks to their portfolios. Many across Wall Street feel that the sector will continue to remain strong in…
Among congressional districts, New York's 15th has the highest number of COVID-19 deaths.
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for myelodysplastic syndromes.
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
As with states and cities, COVID-19 case counts vary sharply by congressional district. The district with the highest count covers all of South Dakota.
